Who is sponsoring NCT04683133?

NCT04683133 is sponsored by Erasmus Medical Center.

What drugs are being tested in NCT04683133?

Interventions in NCT04683133: Optical coherence tomography assessment.

What condition does NCT04683133 study?

NCT04683133 studies Tomography, Optical Coherence, Myocardial Revascularization, NSTEMI - Non-ST Segment Elevation MI, Unstable Angina, Coronary Arteriosclerosis, 3D-angio-based FFR.

Is NCT04683133 still recruiting?

NCT04683133 is currently status unknown. Last updated 24 December 2020.

Last reviewed 2020-12-24 · How we verify

NCT04683133

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The FAST OCT Study

Status unknown NA Last updated 24 December 2020

What this trial tests

NA trial testing Optical coherence tomography assessment in Tomography, Optical Coherence in 200 participants. Status unknown.

Timeline

1 December 2020

Primary endpoint
31 December 2021

31 December 2021

Quick facts

Lead sponsor	Erasmus Medical Center
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	200
Start date	1 December 2020
Primary completion	31 December 2021
Estimated completion	31 December 2021
Sites	1 location across Netherlands

Drugs / interventions tested

Optical coherence tomography assessment

Conditions studied

Tomography, Optical Coherence — all drugs for Tomography, Optical Coherence →
Myocardial Revascularization — all drugs for Myocardial Revascularization →
NSTEMI - Non-ST Segment Elevation MI — all drugs for NSTEMI - Non-ST Segment Elevation MI →
Unstable Angina — all drugs for Unstable Angina →

Sponsor

Erasmus Medical Center

Who can join

18 and older, any sex, with Tomography, Optical Coherence or Myocardial Revascularization. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This trial is designed to associate angiography-based fractional flow reserve (3D-angio-based FFR) values with optical coherence tomography findings in pre- and post-percutaneous coronary intervention in patients with non-ST segment elevation acute coronary syndromes.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Association of vessel fractional flow reserve (vFFR) with luminal obstruction and plaque characteristics as detected by optical coherence tomography (OCT) in patients with NSTE-ACS: the FAST OCT study.
Ziedses des Plantes AC, Scoccia A, Groenland FTW, Tovar Forero MN, et al · · 2024 · cited 4× · PMID 39192480 · DOI 10.1093/ehjci/jeae212
Association between post-PCI vessel fractional flow reserve (vFFR) and optical coherence tomography (OCT) findings: Results from the FAST OCT study.
Ziedses des Plantes AC, Scoccia A, Groenland FTW, Tovar Forero MN, et al · · 2025 · cited 3× · PMID 40612540 · DOI 10.1016/j.ijcha.2025.101706

Verify or expand the search:

Other recruiting trials for Tomography, Optical Coherence

Currently open trials in the same condition.

NCT05728216 — Histopathological Analysis of Renal Biopsies With Dynamic Full-field Optical Coherence Tomography, a Comparison to Conve · recruiting
NCT06844942 — Vessel Imaging Using Optical Coherence Tomography for Plaque Morphology and Vessel Fractional Flow Reserve · recruiting

Other Erasmus Medical Center trials

Trials by the same sponsor.

NCT07406269 — Clinical Evaluation of AI Decision Support for Early Rehabilitation After Surgery · NA · not yet recruiting
NCT07402109 — CBCT Guided Markerless SBRT for Renal Cell Cancer · NA · recruiting
NCT07383194 — Prediction Models for LDLT Outcomes · not yet recruiting
NCT07426575 — Evaluating the Usability of New Dialysis Bags · not yet recruiting
NCT07329296 — The Regenerative Capacity of the Donor Liver After Living Donor Liver Transplantation: an Ambidirectional Cohort Study · enrolling by invitation

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04683133 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Erasmus Medical Center
Last refreshed: 24 December 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04683133.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing